Table 1 (abstract P374). See text for description
From: Proceedings of the 25th European Paediatric Rheumatology Congress (PReS 2018)
Male (%) | 10 (50%) |
Median age in years (IQ) | 12 (10-14) |
JIA category | |
 Persistent oligoarticular | 9 (45%) |
 Extended oligoarticular | 3 (15%) |
 Polyarticular rheumatoid factor negative | 3 (15%) |
 Enthesitis-related arthritis | 3 (15%) |
 Psoriathic arthritis | 2 (10%) |
Prednisolone / Methotrexate / Biologic therapy (%) | 1 (5%) / 14 (70%) / 2 (10%) |